Program

St. Louis Children’s Hospital has provided pediatric bone marrow transplants since 1991. Our bone marrow transplant program was the first of its kind in Missouri, created specifically for children. Now, our pediatric Stem Cell Transplant and Cellular Therapy Program offers three types of treatment: stem cell transplant, bone marrow transplant, and cellular therapy

When your child is diagnosed with a brain tumor, you want the best care imaginable. You want the most advanced treatments, experienced specialists and a team focused on your child’s long-term quality of life.

Knowing your child may have an increased risk for cancer can be worrisome. Fortunately, we know genetic testing for cancer can improve the chance of finding and treating some cancers at an early stage.

Children diagnosed with bleeding disorders can lead safe and full lives when they receive proper treatment and manage their conditions.

The Bleeding Disorders Center at St. Louis Children’s Hospital provides you and your child with the education, support and empowerment you need to help your child navigate treatment — and all of life’s possibilities — safely.

The Global Neuro-Oncology Program (GNOP) was established to foster partnerships between Washington University and other institutions throughout the world aimed at addressing disparities in cancer care through research, education, outreach, capacity building and technological innovations.

Funded by a grant from Health Resources and Services Administration (HRSA) for the purpose of improving care and quality of life of people with sickle cell disease in the eight-state region.

Chemotherapy, radiation and surgery are vital treatments for many pediatric cancer patients. But these lifesaving measures can take a toll on young bodies. Some side effects of childhood cancer treatment may not show up for many years. These side effects are called late effects.

Our program consists of eight core faculty members, as well as many highly-skilled fellows, residents, nurse practitioners, nurse coordinators and nurses. This page offers four sections to introduce you to the academic missions of the program, including patient care, research and teaching.

The Investigational Agents and Phase 1 Program offers several treatment regimens that provide the newest drugs and therapies available for children with malignant diseases. Both Phase I and Phase II clinical trials are available for patient enrollment.

Sickle cell disease often impacts all aspects of children’s lives, but it doesn’t have to control their lives. St. Louis Children’s Hospital has the largest and most experienced sickle cell program in Missouri. We help children and families manage this condition and obtain the best quality of life possible.